Cargando…

Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?

Detalles Bibliográficos
Autores principales:	Thanou, A, Munroe, M, Kamp, S, Carthen, F, James, JA, Merrill, JT
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467524/ http://dx.doi.org/10.1186/ar3981

Ejemplares similares

Which outcome measures in SLE clinical trials best reflect medical judgment?
por: Thanou, Aikaterini, et al.
Publicado: (2014)

Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers
por: Arriens, Cristina, et al.
Publicado: (2020)

SLE patients and autoantibody-positive healthy individuals display unique cytokine profiles: shared features of inflammation as well as select features of immunosuppression in autoantibody-positive healthy individuals
por: Ritterhouse, LL, et al.
Publicado: (2012)

Is more involvement needed in the clinical trial design & endpoints?
por: Vroom, Elizabeth
Publicado: (2012)

Impact of heart rate variability, a marker for cardiac health, on lupus disease activity
por: Thanou, Aikaterini, et al.
Publicado: (2016)

Thinking toward improved treatments of systemic lupus erythematosus
por: Hahn, BH, et al.
Publicado: (2012)

Earlier extubation using axillary temperature as the endpoint for rewarming following hypothermic cardiopulmonary bypass
por: Kai, MA, et al.
Publicado: (2001)

Preliminary test of the LFA rapid evaluation of activity in lupus (LFA-REAL): an efficient outcome measure correlates with validated instruments
por: Askanase, Anca, et al.
Publicado: (2015)

Comparison between prognostic scores of patients undergoing cardiac surgery: which is the best score to predict mortality and length of stay in a surgical intensive care unit?
por: Campos, LAA, et al.
Publicado: (2003)

Renal flare as a biomarker of incident and progressive chronic kidney disease in patients with lupus nephritis
por: Parikh, S, et al.
Publicado: (2012)

Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus
por: Mahieu, MA, et al.
Publicado: (2012)

Epigenetics and lupus
por: Richardson, B
Publicado: (2012)

Longitudinal analysis of mRNA transcripts and plasma proteins to define a biomarker associated with lupus disease activity
por: Olferiev, M, et al.
Publicado: (2012)

Improving care quality through hybrid implementation/effectiveness studies: Best practices in design, methods, and measures
por: Cohen, Amy N, et al.
Publicado: (2015)

Spanish project on benchmarks related to recombinant human activated protein C use: best clinical practices identification
por: Martín, MC, et al.
Publicado: (2003)

Lupus skin disease
por: Werth, Victoria P
Publicado: (2014)

DNA repair in lupus
por: Xu, Jiadi, et al.
Publicado: (2014)

Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study
por: Aviña-Zubieta, JA, et al.
Publicado: (2012)

The best diagnostic approach for systemic neonatal infections
por: Pedicino, Roberto, et al.
Publicado: (2015)

Genetic-epigenetic interaction in lupus
por: Sawalha, AH
Publicado: (2012)

Modeling the stochastic behavior of lupus
por: Roopenian, Derry C, et al.
Publicado: (2014)

Fluorescence-based tools to improve biopharmaceutical process development
por: Duarte, Tiago M, et al.
Publicado: (2011)

Professional training and research: which resources?
por: Guidarelli, Lucia
Publicado: (2015)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Microparticles as autoantigens in human and murine lupus
por: Ullal, A, et al.
Publicado: (2012)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Protective natural autoantibodies and lupus pathogenesis
por: Silverman, Gregg J
Publicado: (2014)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

Concurrent use of alcohol and cocaine: which is the best drug choice?
por: Darriba, H. Becerra
Publicado: (2022)

Which skills are necessary for territorial pediatric nurses?
por: Becherucci, Paolo
Publicado: (2014)

Which kind and how much physical activity?
por: Giordano, Ugo
Publicado: (2014)

Nerve transfers which have worked for me
por: Bhatia, Anil
Publicado: (2015)

Which treatment for upper respiratory tract infections?
por: Ferrara, Pietro, et al.
Publicado: (2015)

Which are the duties and the limits of nursing in neonatal ventilation?
por: Muscolo, Salvatore
Publicado: (2015)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

Time to lupus nephritis: impact of gender and ethnicity
por: Seligman, VA, et al.
Publicado: (2001)

Innate sensors for nucleic acids and lupus pathogenesis
por: Theofilopoulos, AN, et al.
Publicado: (2012)

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_04fa73t91c6uitnknhsmprf86u